News that AbbeVie’s (ABBV) Humira drug was granted FDA orphan designation for treatment of non-infectious intermediate posterior pan-uveitis or chronic non-infectious anterior uveitis moved the stock up in yesterday’s trading.
Your May $52.50 options (ABBV140517C00052500) also jumped 46.34%. Sadly, this wasn’t enough for your options to be profitable.
So sell your May $52.50 call options at a loss today before they expire worthless tomorrow.
In addition, I am recommending that you close your position in Thermo Fisher Scientific (TMO) at a slight gain as that stock has lost momentum since peaking in early March.
Seven tips to day-trade with a signal can put people on a profitable path if…
Over the past two weeks, investors have been on the receiving end of several key…
Do you know what inflation and the recent college protests have in common? They’re the…
When looking to invest in the S&P 500, SPX and SPY options are similar assets…
An index option is a contract that gives the buyer the right, but not the…
“There’s more wisdom in your book than four years of college education!” -- Subscriber Back…